Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

New drug-delivering nanoparticle could offer better way to treat brain tumors

Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months.

25 May 2018

Study: Breast cancer survivors do not receive recommended level of screening after surgery

Breast cancer survivors are not getting the recommended level of screening, post-surgery, according to a newly-published study in JNCCN – Journal of the National Comprehensive Cancer Network.

24 May 2018

International researchers succeed in stopping growth of mesothelioma in model animals

An international team led by researchers from the Technion-Israel Institute of Technology and NYU Langone Health have succeeded in stopping the growth of mesothelioma in model animals by inhibiting the heparanase enzyme.

24 May 2018

Researchers take important step toward finding protein biomarkers during cancer surgery

Isabelle Fournier and her team are out to change surgical oncology. "Better surgery is associated with better prognosis and higher survival," said Fournier, a professor at the University of Lille and co-director of a proteomics center of INSERM, the French national institute of health.

24 May 2018

Study finds no link between surveillance intensity and detection of recurrence or survival in CRC patients

A national retrospective study led by researchers at The University of Texas MD Anderson Cancer Center found no association between intensity of post-treatment surveillance and detection of recurrence or overall survival in patients with stage I, II or III colorectal cancer.

23 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

How can we detect cancer and viruses with high sensitivity? Physical chemist Laura Fabris - an associate professor in the Materials Science and Engineering Department at Rutgers, the State University of New Jersey, and principal investigator of the Fabris NanoBio Group - is addressing this very question.

22 May 2018

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Thyroid tumors may be more susceptible to precisely targeted radiation treatment, suggests study

Anaplastic thyroid cancer is almost uniformly fatal, with an average lifespan of about 5 months after diagnosis.

22 May 2018

Researchers create tool to determine patient's response to immunotherapy drugs

Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients respond to new immune-based treatments.

21 May 2018

Speakers announced for National Medicines Symposium 2018

NPS MedicineWise is pleased to announce the keynote speakers for the 10th National Medicines Symposium (NMS) - Population to Personal Health Care: The Future is Now.

21 May 2018

Researchers use MR spectroscopy to investigate mechanisms behind targeted treatment for gliomas

Using a novel imaging method, a Massachusetts General Hospital research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas.

21 May 2018

Johns Hopkins' new project helps improve clinician response to deteriorating patient conditions

A project in the radiation oncology outpatient unit at Johns Hopkins Hospital showed an improvement in clinician's comfort level in responding to urgent patient care situations after a department-wide exercise focused on recognizing the signs when a patient's condition was declining during their appointments.

18 May 2018

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

KARL STORZ Endoscopy-America, Inc., announces the commercial launch of the PDD Blue Light Flexible Video Cystoscopy System for enhanced detection of non-muscle invasive bladder cancer.

18 May 2018

Rutgers Cancer Institute nurses research various topics to enhance patient experience

From peer and patient education to addressing treatment side effects and other patient care needs, nurses at Rutgers Cancer Institute of New Jersey researched a number of topics with an aim of enhancing the patient experience.

18 May 2018

Developing a High Throughput Mass Spectrometry Platform for Drug Discovery

Prof. Jonathan Wingfield, AstraZeneca, describes the collaboration with Labcyte and Waters to develop a high throughput mass spectrometry platform.

From Pittcon 18 May 2018

Researchers develop new technology that will impact design of drug delivery systems

Researchers at Houston Methodist and Rice University have made a discovery that will impact the design of not only drug delivery systems, but also the development of newer applications in water filtration and energy production.

18 May 2018

Ovarian cancer therapy may help treat patients with aggressive pancreatic cancer

A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

18 May 2018

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time.

17 May 2018

New treatment regimen boosts survival for young adults and children with T-cell malignancies

In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.

17 May 2018

Oncology News and Research

Further Reading

New drug-delivering nanoparticle could offer better way to treat brain tumors

Study: Breast cancer survivors do not receive recommended level of screening after surgery

International researchers succeed in stopping growth of mesothelioma in model animals

Researchers take important step toward finding protein biomarkers during cancer surgery

Study finds no link between surveillance intensity and detection of recurrence or survival in CRC patients

Celgene to share new and updated data around novel hematological therapies

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

Thyroid tumors may be more susceptible to precisely targeted radiation treatment, suggests study

Researchers create tool to determine patient's response to immunotherapy drugs

Speakers announced for National Medicines Symposium 2018

Researchers use MR spectroscopy to investigate mechanisms behind targeted treatment for gliomas

Johns Hopkins' new project helps improve clinician response to deteriorating patient conditions

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

Rutgers Cancer Institute nurses research various topics to enhance patient experience

Developing a High Throughput Mass Spectrometry Platform for Drug Discovery

Researchers develop new technology that will impact design of drug delivery systems

Ovarian cancer therapy may help treat patients with aggressive pancreatic cancer

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

New treatment regimen boosts survival for young adults and children with T-cell malignancies

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News